Target Name: NPM1P42
NCBI ID: G729686
Review Report on NPM1P42 Target / Biomarker Content of Review Report on NPM1P42 Target / Biomarker
NPM1P42
Other Name(s): nucleophosmin 1 pseudogene 42 | Nucleophosmin 1 (nucleolar phosphoprotein B23, numatrin) pseudogene 42

Understanding NPM1P42: A Potential Drug Target Or Biomarker

NPM1P42, also known as nucleophosmin 1 pseudogene 42, is a gene that has been identified as a potential drug target or biomarker in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. NPM1P42 is a protein that is expressed in various tissues and cells in the body, including the brain, heart, liver, and muscle. It is a key component of the nucleosome, which is the basic unit of DNA in cells.

One of the unique features of NPM1P42 is its potential to interact with a variety of different drugs. This is because the gene is involved in a wide range of cellular processes, including DNA replication, transcription, and repair. As a result, drugs that target NPM1P42 have the potential to inhibit these processes and cause a range of different side effects.

One of the primary targets for NPM1P42 is the tyrosine kinase inhibitor erlotinib. Erlotinib is an oral drug that is used to treat various types of cancer, including lung cancer, colorectal cancer, and abdominal pain. It works by inhibiting the activity of the tyrosine kinase, which is a protein that is involved in cell signaling. This can lead to the inhibition of cell growth and the inhibition of the formation of new blood vessels, which can be beneficial in treating cancer.

Another potential target for NPM1P42 is the protein p16INK4a. p16INK4a is a gene that is involved in cell signaling and has been linked to a wide range of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. It is expressed in various tissues and cells in the body, including the brain, and has been shown to be involved in the development and progression of cancer.

In addition to its potential as a drug target, NPM1P42 has also been identified as a potential biomarker. This is because it is expressed in a wide range of tissues and cells in the body, including the brain, heart, and liver. This makes it a potential candidate for use as a diagnostic marker in a variety of diseases, including cancer.

One of the challenges in studying NPM1P42 as a potential drug target or biomarker is its complex role in various cellular processes. This makes it difficult to understand exactly how the protein functions and how it can be targeted by drugs. Additionally, the wide range of tissues and cells that NPM1P42 is expressed in makes it difficult to study its effects in a specific context.

Despite these challenges, research into NPM1P42 is ongoing, and there is growing interest in its potential as a drug target or biomarker. As more research is done, it is likely that the full potential of NPM1P42 will be understood, and its uses in the clinic will continue to expand.

Protein Name: Nucleophosmin 1 Pseudogene 42

The "NPM1P42 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NPM1P42 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

NPM1P47 | NPM1P48 | NPM2 | NPM3 | NPNT | NPPA | NPPA-AS1 | NPPB | NPPC | NPR1 | NPR2 | NPR3 | NPRL2 | NPRL3 | NPS | NPSR1 | NPSR1-AS1 | NPTN | NPTN-IT1 | NPTX1 | NPTX2 | NPTXR | NPVF | NPW | NPY | NPY1R | NPY2R | NPY4R | NPY4R2 | NPY5R | NPY6R | NQO1 | NQO2 | NR0B1 | NR0B2 | NR1D1 | NR1D2 | NR1H2 | NR1H3 | NR1H4 | NR1I2 | NR1I3 | NR2C1 | NR2C2 | NR2C2AP | NR2E1 | NR2E3 | NR2F1 | NR2F1-AS1 | NR2F2 | NR2F2-AS1 | NR2F6 | NR3C1 | NR3C2 | NR4A1 | NR4A2 | NR4A3 | NR5A1 | NR5A2 | NR6A1 | NRAD1 | NRADDP | NRAP | NRARP | NRAS | NRAV | NRBF2 | NRBF2P4 | NRBP1 | NRBP2 | NRCAM | NRDC | NRDE2 | NREP | NRF1 | NRG1 | NRG2 | NRG3 | NRG4 | NRGN | NRIP1 | NRIP2 | NRIP3 | NRIP3-DT | NRIR | NRK | NRL | NRM | NRN1 | NRN1L | NRON | NRP1 | NRP2 | NRROS | NRSN1 | NRSN2 | NRSN2-AS1 | NRTN | NRXN1 | NRXN2